BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 17101149)

  • 21. One-step affinity purification of recombinant urokinase-type plasminogen activator receptor using a synthetic peptide developed by combinatorial chemistry.
    Jacobsen B; Gårdsvoll H; Juhl Funch G; Ostergaard S; Barkholt V; Ploug M
    Protein Expr Purif; 2007 Apr; 52(2):286-96. PubMed ID: 17027282
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Group A streptococcal surface GAPDH, SDH, recognizes uPAR/CD87 as its receptor on the human pharyngeal cell and mediates bacterial adherence to host cells.
    Jin H; Song YP; Boel G; Kochar J; Pancholi V
    J Mol Biol; 2005 Jul; 350(1):27-41. PubMed ID: 15922359
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of a new epitope in uPAR as a target for the cancer therapeutic monoclonal antibody ATN-658, a structural homolog of the uPAR binding integrin CD11b (αM).
    Xu X; Cai Y; Wei Y; Donate F; Juarez J; Parry G; Chen L; Meehan EJ; Ahn RW; Ugolkov A; Dubrovskyi O; O'Halloran TV; Huang M; Mazar AP
    PLoS One; 2014; 9(1):e85349. PubMed ID: 24465541
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Urokinase receptor variants in tissue and body fluids.
    Høyer-Hansen G; Lund IK
    Adv Clin Chem; 2007; 44():65-102. PubMed ID: 17682340
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The crystal structure of the antibody N10-staphylococcal nuclease complex at 2.9 A resolution.
    Bossart-Whitaker P; Chang CY; Novotny J; Benjamin DC; Sheriff S
    J Mol Biol; 1995 Nov; 253(4):559-75. PubMed ID: 7473734
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interplay of human tissue kallikrein 4 (hK4) with the plasminogen activation system: hK4 regulates the structure and functions of the urokinase-type plasminogen activator receptor (uPAR).
    Beaufort N; Debela M; Creutzburg S; Kellermann J; Bode W; Schmitt M; Pidard D; Magdolen V
    Biol Chem; 2006 Feb; 387(2):217-22. PubMed ID: 16497155
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stabilizing a flexible interdomain hinge region harboring the SMB binding site drives uPAR into its closed conformation.
    Zhao B; Gandhi S; Yuan C; Luo Z; Li R; Gårdsvoll H; de Lorenzi V; Sidenius N; Huang M; Ploug M
    J Mol Biol; 2015 Mar; 427(6 Pt B):1389-1403. PubMed ID: 25659907
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The crystal structure of the pathogenic collagen type II-specific mouse monoclonal antibody CIIC1 Fab: structure to function analysis.
    Uysal H; Sehnert B; Nandakumar KS; Böiers U; Burkhardt H; Holmdahl R; Thunnissen MM
    Mol Immunol; 2008 Apr; 45(8):2196-204. PubMed ID: 18241923
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structural analysis and tissue localization of human C4.4A: a protein homologue of the urokinase receptor.
    Hansen LV; Gårdsvoll H; Nielsen BS; Lund LR; Danø K; Jensen ON; Ploug M
    Biochem J; 2004 Jun; 380(Pt 3):845-57. PubMed ID: 15012588
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metabolism of tumour-derived urokinase receptor and receptor fragments in cancer patients and xenografted mice.
    Sier CF; Nicoletti I; Santovito ML; Frandsen T; Aletti G; Ferrari A; Lissoni A; Giavazzi R; Blasi F; Sidenius N
    Thromb Haemost; 2004 Feb; 91(2):403-11. PubMed ID: 14961171
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Soluble urokinase receptor promotes cell adhesion and requires tyrosine-92 for activation of p56/59(hck).
    Trigwell S; Wood L; Jones P
    Biochem Biophys Res Commun; 2000 Nov; 278(2):440-6. PubMed ID: 11097855
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The uPA receptor and the somatomedin B region of vitronectin direct the localization of uPA to focal adhesions in microvessel endothelial cells.
    Salasznyk RM; Zappala M; Zheng M; Yu L; Wilkins-Port C; McKeown-Longo PJ
    Matrix Biol; 2007 Jun; 26(5):359-70. PubMed ID: 17344041
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Crystal structure of the disulfide-stabilized Fv fragment of anticancer antibody B1: conformational influence of an engineered disulfide bond.
    Almog O; Benhar I; Vasmatzis G; Tordova M; Lee B; Pastan I; Gilliland GL
    Proteins; 1998 May; 31(2):128-38. PubMed ID: 9593187
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structural details of HIV-1 recognition by the broadly neutralizing monoclonal antibody 2F5: epitope conformation, antigen-recognition loop mobility, and anion-binding site.
    Julien JP; Bryson S; Nieva JL; Pai EF
    J Mol Biol; 2008 Dec; 384(2):377-92. PubMed ID: 18824005
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structure of IL-17A in complex with a potent, fully human neutralizing antibody.
    Gerhardt S; Abbott WM; Hargreaves D; Pauptit RA; Davies RA; Needham MR; Langham C; Barker W; Aziz A; Snow MJ; Dawson S; Welsh F; Wilkinson T; Vaugan T; Beste G; Bishop S; Popovic B; Rees G; Sleeman M; Tuske SJ; Coales SJ; Hamuro Y; Russell C
    J Mol Biol; 2009 Dec; 394(5):905-21. PubMed ID: 19835883
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reduced release of intact and cleaved urokinase receptor in stimulated whole-blood cultures from human immunodeficiency virus-1-infected patients.
    Ostrowski SR; Piironen T; Høyer-Hansen G; Gerstoft J; Pedersen BK; Ullum H
    Scand J Immunol; 2005 Apr; 61(4):347-56. PubMed ID: 15853918
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential proteome expression associated with urokinase plasminogen activator receptor (uPAR) suppression in malignant epithelial cancer.
    Saldanha RG; Xu N; Molloy MP; Veal DA; Baker MS
    J Proteome Res; 2008 Nov; 7(11):4792-806. PubMed ID: 18808175
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dynamics of urokinase receptor interaction with Peptide antagonists studied by amide hydrogen exchange and mass spectrometry.
    Jørgensen TJ; Gårdsvoll H; Danø K; Roepstorff P; Ploug M
    Biochemistry; 2004 Nov; 43(47):15044-57. PubMed ID: 15554712
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cross-reactivity studies of an anti-Plasmodium vivax apical membrane antigen 1 monoclonal antibody: binding and structural characterisation.
    Igonet S; Vulliez-Le Normand B; Faure G; Riottot MM; Kocken CH; Thomas AW; Bentley GA
    J Mol Biol; 2007 Mar; 366(5):1523-37. PubMed ID: 17229439
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comprehensive functional maps of the antigen-binding site of an anti-ErbB2 antibody obtained with shotgun scanning mutagenesis.
    Vajdos FF; Adams CW; Breece TN; Presta LG; de Vos AM; Sidhu SS
    J Mol Biol; 2002 Jul; 320(2):415-28. PubMed ID: 12079396
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.